Veterinary Medicines

Doxyveto-C 500 mg/g Powder for use in drinking water/milk

Authorised
  • Doxycycline hyclate
Download as PDF

Product identification

Medicine name:
Doxyveto-C 500 mg/g Powder for use in drinking water/milk
Doxyveto-C 500 mg/g Powder for use in drinking water/milk
DOXYCYCLINE VMD 500 MG/G ΚΟΝΙΣ ΓΙΑ ΧΟΡΗΓΗΣΗ ΜΕ ΠΟΣΙΜΟ ΝΕΡΟ/ΓΑΛΑ
Active substance:
  • Doxycycline hyclate
Target species:
  • Cattle (pre-ruminant)
  • Pig
  • Chicken (broiler)
  • Chicken (layer hen)
  • Chicken (pullet future breeder)
Route of administration:
  • In drinking water/milk use

Product details

Active substance and strength:
  • Doxycycline hyclate
    500.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Powder for use in drinking water/milk
Withdrawal period by route of administration:
  • In drinking water/milk use
    • Cattle (pre-ruminant)
      • Meat and offal
        7
        day
      • Milk
        no withdrawal period
    • Pig
      • Meat and offal
        8
        day
    • Chicken (broiler)
      • Meat and offal
        5
        day
      • Egg
        no withdrawal period
    • Chicken (layer hen)
      • Egg
        no withdrawal period
      • Meat and offal
        5
        day
    • Chicken (pullet future breeder)
      • Meat and offal
        5
        day
      • Egg
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01AA02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:
  • Doxyveto-C 500 mg/g pwdr. for drinking water/milk 1 kg
  • Doxyveto-C 500 mg/g pwdr. for drinking water/milk jar 1 kg
  • Doxyveto-C 500 mg/g pwdr. for drinking water/milk jar 100 g

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 18 of Regulation (EU) 2019/6)
Marketing authorisation holder:
  • V.M.D.
Marketing authorisation date:
Manufacturing sites for batch release:
  • V.M.D.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 77610/05-07-2024/K-0224601
Date of authorisation status change:
Reference member state:
  • Belgium
Procedure number:
  • BE/V/0032/001
Concerned member states:
  • Bulgaria
  • Croatia
  • France
  • Greece
  • Hungary
  • Luxembourg
  • Netherlands
  • Portugal
  • Romania
  • Spain
  • United Kingdom (Northern Ireland)
Generic of:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 20/08/2024
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 20/08/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."